End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.41 CNY | -0.27% | +3.49% | -24.00% |
10/04 | Lanzhou Foci Pharmaceutical Chairman Resigns | MT |
10/04 | Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
Sales 2022 | 1.02B 141M 11.73B | Sales 2023 | 1.16B 161M 13.38B | Capitalization | 4.98B 687M 57.29B |
---|---|---|---|---|---|
Net income 2022 | 106M 14.63M 1.22B | Net income 2023 | 67M 9.25M 771M | EV / Sales 2022 | 4.34 x |
Net cash position 2022 | 344M 47.44M 3.96B | Net cash position 2023 | 353M 48.77M 4.07B | EV / Sales 2023 | 3.98 x |
P/E ratio 2022 |
45
x | P/E ratio 2023 |
74.1
x | Employees | 1,353 |
Yield 2022 |
0.54% | Yield 2023 |
0.31% | Free-Float | 34.04% |
1 day | -0.27% | ||
1 week | +3.49% | ||
Current month | -7.84% | ||
1 month | -5.24% | ||
3 months | -10.72% | ||
6 months | -28.95% | ||
Current year | -24.00% |
Managers | Title | Age | Since |
---|---|---|---|
Ai Guo Shi
CEO | Chief Executive Officer | 60 | 30/17/30 |
Jin feng Yue
DFI | Director of Finance/CFO | - | 02/22/02 |
Li Jun Wu
BRD | Director/Board Member | 50 | 01/91/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Guo Xian Bao
BRD | Director/Board Member | 69 | 12/22/12 |
Xin Min Zhao
BRD | Director/Board Member | 54 | 02/20/02 |
Guo Lin Chai
PRN | Corporate Officer/Principal | 57 | 08/99/08 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 7.41 | -0.27% | 4,325,600 |
25/24/25 | 7.43 | +1.23% | 3,677,500 |
24/24/24 | 7.34 | +0.82% | 2,884,700 |
23/24/23 | 7.28 | +1.53% | 4,186,200 |
22/24/22 | 7.17 | +0.14% | 4,370,250 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-24.00% | 522M | |
+35.04% | 5.92B | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
-7.89% | 1.68B | |
+0.09% | 1.65B | |
-12.97% | 1.53B |
- Stock Market
- Equities
- 002644 Stock